United States:
FDA Announces Fee Rates For Using Tropical Disease Priority Review Voucher In FY2015
15 September 2014
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
In the August 27, 2014, Federal Register, FDA announced the
fee rate for tropical disease priority review vouchers, in addition
to the normal PDUFA fee, will be $2,562,000. The user fee is
effective for any application received on or after October 1, 2014,
and is due upon submission of the drug application along with any
other fee due under PDUFA.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
